SPU [SkyPeople Fruit Juice] 8-K: (Original Filing)

[COMPANY SkyPeople Fruit Juice, Inc. Mr. Xin Ma , Vice President Tel: China + 86 - 29-8837-7161 Email: oliver.x.ma@skypeoplefruitjuice.com Web: http://www.skypeoplefruitjuice.com INVESTOR RELATIONS David Rudnick , Account Manager CCG Investor Relations Tel: US +1- 646 - 626-4172 Email: david.rudnick@ccgir.com Web: http://www.ccgir.com SkyPeople Fruit Juice New Beverage Production Line Started Operation in Northeastern China 2 SPU News in Huludao Wonder Fruit] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): April 30, 2012 SKYPEOPLE FRUIT JUICE, INC. Florida 001-34502 98-0222013 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 16F, China Development Bank Tower, No. 2, Gaoxin 1st Road, Xi’an, PRC 710075 (Zip code) 86-29-88377161]

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[AMENDMENTREEMENT TO NON-QUALIFIED STOCK OPTIONREEMENTS OF CHINA PHARMAS, WHEREAS, the Employmentreement by and between thempany and the Optionee will cease its effect of April 28, 2012; WHEREAS, the Nominating andmpensationmmittee believes it is for the best interest of thempany to terminate the Subject Options on April 28, 2012 and the Optioneereed to.]

By | 2016-02-07T22:02:28+00:00 April 30th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: AMENDMENTREEMENT TO NON-QUALIFIED STOCK OPTIONREEMENTS OF CHINA PHARMAS,

[AMENDMENTREEMENT TO NON-QUALIFIED STOCK OPTIONREEMENTS OF CHINA PHARMAS, WHEREAS, the Employmentreement by and between thempany and the Optionee will cease its effect of April 28, 2012; WHEREAS, the Nominating andmpensationmmittee believes it is for the best interest of thempany to terminate the Subject Options on April 28, 2012 and the Optioneereed to.]

By | 2016-02-07T22:03:02+00:00 April 30th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Item 5.07 Submission of Matters to a Vote of Security Holders On April 27, 2012,ystar Bio-Pharmaceuticalmpany (thempany) held its Annual Meeting of Shareholders. Set forth below are the matters voted upon at the meeting and the voting results: Proposal 1 Name Votes For Votes Withheld Weibing Lu 2,655,555]

By | 2016-02-05T03:17:17+00:00 April 27th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Item 5.07 Submission of Matters to a Vote

[Item 5.07 Submission of Matters to a Vote of Security Holders On April 27, 2012,ystar Bio-Pharmaceuticalmpany (thempany) held its Annual Meeting of Shareholders. Set forth below are the matters voted upon at the meeting and the voting results: Proposal 1 Name Votes For Votes Withheld Weibing Lu 2,655,555]

By | 2016-02-05T03:18:11+00:00 April 27th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO BEIJING, China, April 27, 2012 /PRNewswire via COMTEX/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced the resignation of Chief Financial Officer, Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 26, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

CBPO [China Biologic Products] 8-K: China Biologic Has Announced the Resignation of CFO

[China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO BEIJING, China, April 27, 2012 /PRNewswire via COMTEX/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced the resignation of Chief Financial Officer, Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 26, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic’s Board Has Appointed Two New Independent Directors to Boost Corporate Governance BEIJING, China, April 25, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced that effective April 20, 2012, the Company’s Board of Directors (the “Board”) has appointed Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 (Former name or former address, if changed since]

Skip to toolbar